GGI
ACHV icon

Godsey & Gibb Inc’s Achieve Life Sciences ACHV Stock Holding History

Godsey & Gibb Inc’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-453
Closed -$1.87K – 387
2023
Q4 		$1.87K Hold
453
– – ﹤0.01% 327
2023
Q3 		$1.95K Hold
453
– – ﹤0.01% 307
2023
Q2 		$2.35K Hold
453
– – ﹤0.01% 330
2023
Q1 		$3.08K Hold
453
– – ﹤0.01% 291
2022
Q4 		$1.11K Hold
453
– – ﹤0.01% 279
2022
Q3 		$1K Buy
+453
New +$2.16K ﹤0.01% 78
2022
Q2 		– Sell
-453
Closed -$3K – 105
2022
Q1 		$3K Buy
+453
New +$3.37K ﹤0.01% 93
2021
Q4 		– Sell
-453
Closed -$4K – 100
2021
Q3 		$4K Buy
+453
New +$3.55K ﹤0.01% 82

Other funds holding ACHV

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

Godsey & Gibb Inc's ACHV Position: Q1 2024 in Review

Godsey & Gibb Inc sold out of Achieve Life Sciences (ACHV) in Q1 2024, closing a stake of 453 shares — an estimated $1.87K sold.

Godsey & Gibb Inc first reported a position in ACHV in Q3 2021 and held it in 8 quarters. The position peaked at $4K in Q3 2021. 41 funds tracked by Wall St. Rank hold ACHV as of Q1 2024.

  • Godsey & Gibb Inc reported no remaining Achieve Life Sciences position as of Q1 2024 after selling out during the quarter.
  • Godsey & Gibb Inc sold 453 Achieve Life Sciences shares in Q1 2024, an estimated $1.87K.
  • Godsey & Gibb Inc first reported a position in Achieve Life Sciences in Q3 2021 and held it in 8 quarters.
  • Godsey & Gibb Inc's Achieve Life Sciences position peaked at $4K in Q3 2021.
  • 41 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2024.

Based on Godsey & Gibb Inc's 13F filing for Q1 2024, filed 23 Apr 2024.